7 completed. 3 Phase 3, 2 Not applicable, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Not applicable | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Fendrix: new trials by email Literature Review of Fendrix trials Research Report on Fendrix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, GSK's HBsAg candidate vaccine adjuvanted with GSK's AS03 adjuvant system, GSK's Hepatitis B vaccine adjuvanted with GSK's AS04 adjuvant system - Hepatitis B | Phase 1 | Completed | GlaxoSmithKline | 122 | 2022-10-04 | 2026-01-15 |
| Efficacy of HBVaxpro40© and Fendrix© in Patients With Chronic Liver Disease. Fendrix or HBVAXPRO 40 - Liver Disease Chronic, Hepatitis B Virus | Not applicable | Completed | Corporacion Parc Tauli | 125 | 2017-09-01 | 2022-07-11 |
| A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses Engerix B, Fendrix - HIV, Communicable Diseases | Phase 2 / Phase 3 | Completed | Sheffield Teaching Hospitals NHS Foundation Trust | 13 | 2015-07-23 | 2022-09-29 |
| Gene Expression Profiles in Muscle After Immunisation Fluad, Fendrix, Placebo - Healthy | Not applicable | Completed | University of Surrey | 45 | 2015-02-01 | 2015-08-10 |
| Safety and Immunogenicity of HEPLISAV™ a Hepatitis B Virus Vaccine in Adults on Hemodialysis HEPLISAV, Engerix-B, Fendrix - End Stage Renal Disease | Phase 3 | Completed | Dynavax Technologies Corporation | 155 | 2010-12-01 | 2019-03-20 |
| Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine Engerix-B™, Fendrix™, GSK Biologicals' Hepatitis B vaccines (GSK223192A) - Hepatitis B | Phase 2 | Completed | GlaxoSmithKline | 713 | 2008-12-15 | 2018-08-20 |
| A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B. Henogen HBV vaccine, FENDRIX - Hepatitis B | Phase 3 | Completed | Henogen | 300 | 2006-02-01 | 2008-08-28 |
Hepatitis B (6) · Communicable Diseases (1) · Hepatitis (1) · Kidney Failure, Chronic (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1)
GlaxoSmithKline (2) · Corporacion Parc Tauli (1) · Dynavax Technologies Corporation (1) · Henogen (1) · Sheffield Teaching Hospitals NHS Foundation Trust (1) · University of Surrey (1)
Belgium (3) · Germany (3) · United Kingdom (3) · Czechia (1) · Hungary (1) · Spain (1)
Aldona Greenwood (1) · Christian Tielemans, MD, PhD (1) · Diana Horta (1)
PMID 28855902, PMID 30850240, PMID 32677968, PMID 33177181, PMID 33493551, PMID 39206189